Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time-Reference-Cited by-同舟云学术

Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time

Published:2019 Issue: Volume:90 Page:1-7
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Coenen Marieke J.H.^ORCID,Paulussen Aimée D.C.,Breuer Marc^ORCID,Lindhout Martijn,Tserpelis Demis C.J.,Steyls Anja,Bierau Jörgen,van den Bosch Bianca J.C.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing;Caudle;Clin Pharmacol Ther,2013

2. Dihydropyrimidinase deficiency: Phenotype, genotype and structural consequences in 17 patients;van Kuilenburg;Biochim Biophys Acta,2010

3. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity;Amstutz;Pharmacogenomics,2011

4. Comparative functional analysis of DPYD variants of potential clinical relevance to dihydropyrimidine dehydrogenase activity;Offer;Cancer Res,2014

5. Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data;Meulendijks;Lancet Oncol,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DPYD Genotyping Recommendations;The Journal of Molecular Diagnostics;2024-07

2. Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics;Exploration of Targeted Anti-tumor Therapy;2024-04-24

3. Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis;British Journal of Cancer;2024-01-15

4. Implementation of upfront DPYD genotyping with a low-cost and high-throughput assay to guide fluoropyrimidine treatment in cancer patients;Pharmacogenetics and Genomics;2023-08-24

5. Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase;Clinical and Translational Science;2021-12-04